Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The scarcity and preciousness of plateau characteristic medicinal plants pose a significant challenge in obtaining sufficient quantities of experimental samples for quality evaluation. Insufficient sample sizes often lead to ambiguous and questionable quality assessments and suboptimal performance in pattern recognition. Shilajit, a popular Tibetan medicine, is harvested from high altitudes above 2000 m, making it difficult to obtain. Additionally, the complex geographical environment results in low uniformity of Shilajit quality.

Methods: To address these challenges, this study employed a deep learning model, time vector quantization variational auto- encoder (TimeVQVAE), to generate data matrices based on chromatographic and spectral for different grades of Shilajit, thereby increasing in the amount of data. Partial least squares discriminant analysis (PLS-DA) was used to identify three grades of Shilajit samples based on original, generated, and combined data.

Results: Compared with the originally generated high performance liquid chromatography (HPLC) and Fourier transform infrared spectroscopy (FTIR) data, the data generated by TimeVQVAE effectively preserved the chemical profile. In the test set, the average matrices for HPLC, FTIR, and combined data increased by 32.2%, 15.9%, and 23.0%, respectively. On the real test data, the PLS-DA model's classification accuracy initially reached a maximum of 0.7905. However, after incorporating TimeVQVAE-generated data, the accuracy significantly improved, reaching 0.9442 in the test set. Additionally, the PLS-DA model trained with the fused data showed enhanced stability.

Conclusion: This study offers a novel and effective approach for researching medicinal materials with small sample sizes, and addresses the limitations of improving model performance through data augmentation strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608951PMC
http://dx.doi.org/10.3389/fphar.2024.1503508DOI Listing

Publication Analysis

Top Keywords

data
10
hplc ftir
8
ftir data
8
tibetan medicine
8
sample sizes
8
grades shilajit
8
test set
8
shilajit
5
efficient generation
4
generation hplc
4

Similar Publications

Purpose Of Review: Sulbactam-durlobactam (SUL-DUR) is a novel β-lactam/β-lactamase inhibitor combination recently approved for carbapenem-resistant Acinetobacter baumannii (CRAB) infections. This review summarizes current knowledge on the optimal use of SUL-DUR, whether administered alone or in combination with carbapenems, particularly imipenem.

Recent Findings: Data from registrational trial demonstrate that SUL-DUR is an effective and well tolerated treatment option for CRAB severe infections.

View Article and Find Full Text PDF

Background: We investigated circulating protein profiles and molecular pathways among various chronic kidney disease (CKD) etiologies to study its underlying molecular heterogeneity.

Methods: We conducted a proteomic biomarker analysis in the DAPA-CKD trial recruiting adults with and without type 2 diabetes with an eGFR of 25 to 75 mL/min/1.73m2 and a UACR of 200 to 5000 mg/g.

View Article and Find Full Text PDF

Background: Poor recovery of active glenohumeral external rotation (aGHER) after brachial plexus birth injury (BPBI) is common. Late spinal accessory nerve to infraspinatus motor branch (SAN-IS) transfer has been reported as effective. We investigated its efficacy in children over 4 years with BPBI.

View Article and Find Full Text PDF

Background: Children in low- and middle-income countries face obstacles to optimal language and cognitive development due to a variety of factors related to adverse socioeconomic conditions. One of these factors is compromised caregiver-child interactions and associated pressures on parenting. Early development interventions, such as dialogic book-sharing (DBS), address this variable, with evidence from both high-income countries and urban areas of low- and middle-income countries showing that such interventions enhance caregiver-child interaction and the associated benefits for child cognitive and socioemotional development.

View Article and Find Full Text PDF

Aims: There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA.

Methods: This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS.

View Article and Find Full Text PDF